Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors

被引：0
|
作者：
Reinhardt, H. C. [1 ]
Chen, S. [1 ]
Daheim, M. [1 ]
Riabinska, A. [1 ]
Boucas, J. [1 ]
机构：
[1] Uniklin, Cologne, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types
    Jessica Xin Hjaltelin
    Jose M. G. Izarzugaza
    Lars Juhl Jensen
    Francesco Russo
    David Westergaard
    Søren Brunak
    npj Systems Biology and Applications, 5
  • [42] Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types
    Hjaltelin, Jessica Xin
    Izarzugaza, Jose M. G.
    Jensen, Lars Juhl
    Russo, Francesco
    Westergaard, David
    Brunak, Soren
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2019, 5
  • [43] Elucidation of tonic and activated B cell receptor signaling in Burkitt's lymphoma reveals insights into non-oncogene addiction
    Walter, R.
    Corso, J.
    Pan, K. -T
    Doebele, C.
    Yepes, D.
    Sellner, L.
    Tomska, K.
    Bohnenberger, H.
    Zenz, T.
    Urlaub, H.
    Serve, H.
    Oellerich, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 219 - 219
  • [44] HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers (vol 17, 149, 2015)
    Putcha, Preeti
    Yu, Jiyang
    Rodriguez-Barrueco, Ruth
    Saucedo-Cuevas, Laura
    Villagrasa, Patricia
    Murga-Penas, Eva
    Quayle, Steven N.
    Yang, Min
    Castro, Veronica
    Llobet-Navas, David
    Birnbaum, Daniel
    Finetti, Pascal
    Woodward, Wendy A.
    Bertucci, Francois
    Alpaugh, Mary L.
    Califano, Andrea
    Silva, Jose
    BREAST CANCER RESEARCH, 2017, 19
  • [45] Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer
    Siringo, Marco
    Baena, Javier
    de Cabo, Helena Bote
    Torres-Jimenez, Javier
    Zurera, Maria
    Zugazagoitia, Jon
    Paz-Ares, Luis
    CANCERS, 2023, 15 (23)
  • [46] MEPED as salvage therapy for relapsed/refractory Hodgkin's lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck
    Harrer, Dennis Christoph
    Lueke, Florian
    Pukrop, Tobias
    Ghibelli, Lina
    Reichle, Albrecht
    Heudobler, Daniel
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [47] Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism
    Morel, D.
    Almouzni, G.
    Soria, J. -C.
    Postel-Vinay, S.
    ANNALS OF ONCOLOGY, 2017, 28 (02) : 254 - 269
  • [48] Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
    Frega, Stefano
    Bonanno, Laura
    Guarneri, Valentina
    Conte, Pierfranco
    Pasello, Giulia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 128 : 19 - 29
  • [49] Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells
    Hedrick, Erik
    Cheng, Yating
    Jin, Un-Ho
    Kim, Kyounghyun
    Safe, Stephen
    ONCOTARGET, 2016, 7 (16) : 22245 - 22256
  • [50] Elevated sortilin expression discriminates functional from non-functional neuroendocrine tumors and enables therapeutic targeting
    Bolduan, Felix
    Wetzel, Alexandra
    Giesecke, Yvonne
    Eichhorn, Ines
    Alenina, Natalia
    Bader, Michael
    Willnow, Thomas E.
    Wiedenmann, Bertram
    Sigal, Michael
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345